These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
510 related articles for article (PubMed ID: 23060451)
1. APOE4-specific changes in Aβ accumulation in a new transgenic mouse model of Alzheimer disease. Youmans KL; Tai LM; Nwabuisi-Heath E; Jungbauer L; Kanekiyo T; Gan M; Kim J; Eimer WA; Estus S; Rebeck GW; Weeber EJ; Bu G; Yu C; Ladu MJ J Biol Chem; 2012 Dec; 287(50):41774-86. PubMed ID: 23060451 [TBL] [Abstract][Full Text] [Related]
2. Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition. Rodriguez GA; Tai LM; LaDu MJ; Rebeck GW J Neuroinflammation; 2014 Jun; 11():111. PubMed ID: 24948358 [TBL] [Abstract][Full Text] [Related]
3. Levels of soluble apolipoprotein E/amyloid-β (Aβ) complex are reduced and oligomeric Aβ increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples. Tai LM; Bilousova T; Jungbauer L; Roeske SK; Youmans KL; Yu C; Poon WW; Cornwell LB; Miller CA; Vinters HV; Van Eldik LJ; Fardo DW; Estus S; Bu G; Gylys KH; Ladu MJ J Biol Chem; 2013 Feb; 288(8):5914-26. PubMed ID: 23293020 [TBL] [Abstract][Full Text] [Related]
4. APOE4 enhances age-dependent decline in cognitive function by down-regulating an NMDA receptor pathway in EFAD-Tg mice. Liu DS; Pan XD; Zhang J; Shen H; Collins NC; Cole AM; Koster KP; Ben Aissa M; Dai XM; Zhou M; Tai LM; Zhu YG; LaDu M; Chen XC Mol Neurodegener; 2015 Mar; 10():7. PubMed ID: 25871877 [TBL] [Abstract][Full Text] [Related]
5. APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice. Kunzler J; Youmans KL; Yu C; Ladu MJ; Tai LM Neurosci Lett; 2014 Feb; 560():131-6. PubMed ID: 24368217 [TBL] [Abstract][Full Text] [Related]
6. Amyloid-β pathology and APOE genotype modulate retinoid X receptor agonist activity in vivo. Tai LM; Koster KP; Luo J; Lee SH; Wang YT; Collins NC; Ben Aissa M; Thatcher GRJ; LaDu MJ J Biol Chem; 2014 Oct; 289(44):30538-30555. PubMed ID: 25217640 [TBL] [Abstract][Full Text] [Related]
7. A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3. Valencia-Olvera AC; Balu D; Bellur S; McNally T; Saleh Y; Pham D; Ghura S; York J; Johansson JO; LaDu MJ; Tai L Alzheimers Res Ther; 2023 Dec; 15(1):216. PubMed ID: 38102668 [TBL] [Abstract][Full Text] [Related]
8. The role of APOE in transgenic mouse models of AD. Balu D; Karstens AJ; Loukenas E; Maldonado Weng J; York JM; Valencia-Olvera AC; LaDu MJ Neurosci Lett; 2019 Aug; 707():134285. PubMed ID: 31150730 [TBL] [Abstract][Full Text] [Related]
9. Human apolipoprotein E redistributes fibrillar amyloid deposition in Tg-SwDI mice. Xu F; Vitek MP; Colton CA; Previti ML; Gharkholonarehe N; Davis J; Van Nostrand WE J Neurosci; 2008 May; 28(20):5312-20. PubMed ID: 18480287 [TBL] [Abstract][Full Text] [Related]
10. A small-molecule TLR4 antagonist reduced neuroinflammation in female E4FAD mice. Balu D; Valencia-Olvera AC; Nguyen A; Patnam M; York J; Peri F; Neumann F; LaDu MJ; Tai LM Alzheimers Res Ther; 2023 Oct; 15(1):181. PubMed ID: 37858252 [TBL] [Abstract][Full Text] [Related]
11. Soluble apoE/Aβ complex: mechanism and therapeutic target for APOE4-induced AD risk. Tai LM; Mehra S; Shete V; Estus S; Rebeck GW; Bu G; LaDu MJ Mol Neurodegener; 2014 Jan; 9():2. PubMed ID: 24386905 [TBL] [Abstract][Full Text] [Related]
12. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice. Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773 [TBL] [Abstract][Full Text] [Related]
13. apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain. Deane R; Sagare A; Hamm K; Parisi M; Lane S; Finn MB; Holtzman DM; Zlokovic BV J Clin Invest; 2008 Dec; 118(12):4002-13. PubMed ID: 19033669 [TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor prevents APOE4 and amyloid-beta-induced cognitive and cerebrovascular deficits in female mice. Thomas R; Zuchowska P; Morris AW; Marottoli FM; Sunny S; Deaton R; Gann PH; Tai LM Acta Neuropathol Commun; 2016 Oct; 4(1):111. PubMed ID: 27788676 [TBL] [Abstract][Full Text] [Related]
15. Estradiol improves behavior in FAD transgenic mice that express Balu D; Valencia-Olvera AC; Deshpande A; Narayanam S; Konasani S; Pattisapu S; York JM; Thatcher GRJ; LaDu MJ; Tai LM Front Endocrinol (Lausanne); 2024; 15():1374825. PubMed ID: 38742194 [TBL] [Abstract][Full Text] [Related]
16. APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1. Tachibana M; Holm ML; Liu CC; Shinohara M; Aikawa T; Oue H; Yamazaki Y; Martens YA; Murray ME; Sullivan PM; Weyer K; Glerup S; Dickson DW; Bu G; Kanekiyo T J Clin Invest; 2019 Mar; 129(3):1272-1277. PubMed ID: 30741718 [TBL] [Abstract][Full Text] [Related]
17. Peripheral Inflammation, Apolipoprotein E4, and Amyloid-β Interact to Induce Cognitive and Cerebrovascular Dysfunction. Marottoli FM; Katsumata Y; Koster KP; Thomas R; Fardo DW; Tai LM ASN Neuro; 2017; 9(4):1759091417719201. PubMed ID: 28707482 [TBL] [Abstract][Full Text] [Related]
18. Blocking the apoE/Aβ interaction ameliorates Aβ-related pathology in APOE ε2 and ε4 targeted replacement Alzheimer model mice. Pankiewicz JE; Guridi M; Kim J; Asuni AA; Sanchez S; Sullivan PM; Holtzman DM; Sadowski MJ Acta Neuropathol Commun; 2014 Jun; 2():75. PubMed ID: 24972680 [TBL] [Abstract][Full Text] [Related]
19. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces Aβ accumulation and plaque-related pathology in a mouse model of amyloidosis. Mahan TE; Wang C; Bao X; Choudhury A; Ulrich JD; Holtzman DM Mol Neurodegener; 2022 Feb; 17(1):13. PubMed ID: 35109920 [TBL] [Abstract][Full Text] [Related]
20. Synergistic effects of APOE and sex on the gut microbiome of young EFAD transgenic mice. Maldonado Weng J; Parikh I; Naqib A; York J; Green SJ; Estus S; LaDu MJ Mol Neurodegener; 2019 Dec; 14(1):47. PubMed ID: 31861986 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]